Aminoguanadine

Aminoguanadine

Aminoguanadine is an exciting new weapon in the armory of anti-aging medicine. It is believed that the cross-linking of the proteins that make up the human body play a role in the human aging process. Cross-linking is medically referred to as Glyco-sylation and it is responsible for many of the problems of old age, including skin aging, senile cataracts, thickening of the arteries, cardiac enlargement, some cancers and damage to the immune system. Aminoguanidine is a potent anti-glycation inhibitor. It helps prevent and also break some protein cross-linking. Animal experiments have shown aminoguanidine to prevent age-related heart enlargement and increase the collagen of arterial walls of aged subjects by 24-30%. Long-term studies conducted in Italy indicate that aminoguanidine reduces the “bad” form of cholesterol (LDL) in humans and improves blood-platelet condition. Recent human and animal studies also indicate that aminoguanidine improves diabetic conditions and improves the survival rates and longevity of animals. It even improves renal (kidney) condition. Most interestingly of all, aminoguanidine may have the potential to slow the aging process by protecting the proteins that make up the human body. Proteins, such as the skin proteins (collagen and elastin), eye-lens protein, nerve protein and kidney proteins. All the body’s proteins deteriorate with advancing age and more so in diabetes (Diabetics have two to three times the number of cross-linked proteins when compared to non-diabetics. This has lead credence to the fact that diabetes can be viewed as a form of accelerated aging).

Featured Member Experts (click on them to view their profiles)